Is Chewy a Growth Stock to Buy?
It might be a surprise to learn that during the…
Sell
26
MNPR Quote, Financials, Valuation and Earnings
Last price:
$32.76
Seasonality move
:
-9.44%
Day range:
$30.80 - $34.30
52-week range:
$1.72 - $54.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.54x
Volume:
13.6K
Avg. volume:
31.3K
1-year change:
895.94%
Market cap:
$194.8M
Revenue:
--
EPS (TTM):
-$1.99
MNPR Analysts' Consensus Rating
The 2 analysts providing 12-month price projections for Monopar Therapeutics shares anticipate an average target of $58.69, ranging from a low estimate of $40.08 to a high estimate of $76.00. This average target implies a growth of 84.17% compared to the current stock price of $31.87.
Consensus Price Target
$58.69
Highest Price Target
$76.00
Lowest Price Target
$40.08
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 2 | 2 | 1 |
| Hold | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Leans Bullish |
MNPR Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 31x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Sell
11
CRL alert for Apr 11
Charles River Laboratories International [CRL] is down 2.53% over the past day.
Buy
77
DPST alert for Apr 11
Direxion Daily Regional Banks Bull 3X Shares [DPST] is down 4.26% over the past day.
Sell
35
KMX alert for Apr 11
CarMax [KMX] is up 1.9% over the past day.
